Dermapharm Holding SE
DMPHF
$38.50
-$2.12-5.23%
OTC PK
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 23.71M | 35.15M | 21.86M | 35.61M | 18.59M |
| Total Depreciation and Amortization | 22.76M | 21.00M | -29.17M | 22.37M | 24.00M |
| Total Amortization of Deferred Charges | -- | -- | 46.40M | -- | -- |
| Total Other Non-Cash Items | 10.24M | -9.44M | 8.78M | 20.60M | -6.43M |
| Change in Net Operating Assets | 18.07M | -42.26M | 28.58M | 2.41M | -11.52M |
| Cash from Operations | 74.79M | 4.45M | 76.46M | 80.99M | 24.64M |
| Capital Expenditure | -11.85M | -10.60M | -12.66M | -8.55M | -12.41M |
| Sale of Property, Plant, and Equipment | 85.10K | 370.40K | 268.60K | 118.70K | 3.57M |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 491.40K | 446.20K | 4.32M | 1.24M | -616.70K |
| Cash from Investing | -11.27M | -9.78M | -8.07M | -7.19M | -9.46M |
| Total Debt Issued | 35.00M | 35.00M | 11.17M | 10.00M | 90.00M |
| Total Debt Repaid | -28.76M | -14.07M | -66.07M | -56.97M | -48.69M |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | 0.00 | -52.09M | -- |
| Other Financing Activities | -12.88M | -21.08M | -7.16M | -19.75M | -6.97M |
| Cash from Financing | -7.54M | -152.60K | -66.15M | -125.44M | 36.96M |
| Foreign Exchange rate Adjustments | -2.05M | -940.80K | 928.50K | -512.30K | -48.40K |
| Miscellaneous Cash Flow Adjustments | 1.10K | -1.10K | 1.10K | -- | -2.20K |
| Net Change in Cash | 53.92M | -6.43M | 3.17M | -52.15M | 52.09M |